A histopathological and pharmacological analysis of the mode of action of nonsteroidal anti-inflammatory drugs.
D000818:Animals; D000893:Anti-Inflammatory Agents; D001241:Aspirin / Q000627:therapeutic use*; D001853:Bone Marrow / Q000528:radiation effects; D002351:Carrageenan; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D007213:Indomethacin / Q000627:therapeutic use*; D007962:Leukocytes / Q000187:drug effects; D008264:Macrophages / Q000187:drug effects; D008297:Male; D008528:Mefenamic Acid / Q000627:therapeutic use*; D008727:Methotrexate / Q000627:therapeutic use*; D010587:Phagocytosis / Q000187:drug effects; D010653:Phenylbutazone / Q000627:therapeutic use*; D010998:Pleurisy / Q000139:chemically induced / Q000188:drug therapy; D011830:Radiation Effects; D051381:Rats; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014425:Turpentine
D000893:Anti-Inflammatory Agents; D014316:Tritium; D008528:Mefenamic Acid; D002351:Carrageenan; D010653:Phenylbutazone; D001241:Aspirin; D013936:Thymidine; D014425:Turpentine; D007213:Indomethacin; D008727:Methotrexate